Patient Guide: A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 172 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06212999
Status: 🟢 Enrolling Now
Condition: Hidradenitis Suppurativa (HS)
Phase: PHASE3

Where You Can Participate

This study is available at 172 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Scottsdale, Arizona
  • • Fort Smith, Arkansas
  • • And 169 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa - Join Clinical Trial NCTNCT06212999

How to Join This Clinical Trial - NCTNCT06212999

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hidradenitis Suppurativa (HS). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hidradenitis Suppurativa (HS). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hidradenitis Suppurativa (HS)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06212999 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 172 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85006 - United States

Status: RECRUITING

Clinical Research Site

Scottsdale, Arizona 85255 - United States

Status: RECRUITING

Clinical Research Site

Fort Smith, Arkansas 72916 - United States

Status: RECRUITING

Clinical Research Site

Rogers, Arkansas 72758 - United States

Status: RECRUITING

Clinical Research Site

Laguna Niguel, California 92677 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90033 - United States

Status: RECRUITING

Clinical Research Site

Oakland, California 94611 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92103 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20060 - United States

Status: WITHDRAWN

Clinical Research Site

Clearwater, Florida 33614 - United States

Status: RECRUITING

And 162 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hidradenitis Suppurativa (HS):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships